Fascinating research from Germany reveals vital difference in antibody response to Omicron versus prior variants
Ongoing study of 1850 children since 2020
Very few developed antibody after Omicron infection (18%), versus 68% for prior variants
1/9
Such meticulously planned studies will help unlock the mysteries of the pandemic.
These authors have tracked 1850 children from the beginning of the pandemic, studying their immune response to infections by various forms of the virus.
2/
They measured antibodies found in blood as well as saliva.
Among children who never had prior infection or vaccination, there was a remarkable difference in their antibody response to various versions of this virus.
3/
We know seroprevalence studies (e.g. Delhi, India) had revealed high percentage of children, near 100%, had developed antibodies even before Omicron arrived (prior tweets)
That’s because children generated a robust humoral (antibody) response to that version of the virus
4/
They also studied a group of vaccinated children, all of whom had developed antibodies. People who had both pre omicron infection and omicron infection also made antibodies.
None of the infections were severe, whether vaccinated or not.
5/
But once omicron arrived, there was a distinct change in immune response, at least among children.
❗️❗️❗️For those who were encountering the virus for the first time, very few in fact developed antibodies in the plasma and saliva (in the case of Omicron)
6/
The study has several implications.
We know that omicron is capable of repeatedly infecting people often without their knowledge.
Authors believe that it is perhaps the failure of antibody response - rather than the quality of antibodies - that results in this phenomenon.
7/
Also tells us that doing serology studies will not help determine how many had omicron infection, because of the failure to generate antibodies. (Of course this only applies to first immune exposure)
8/
People may go through several bouts of omicron infection, because the prior bout might not generate enough antibodies to prevent a subsequent infection.
This could potentially explain the observation of intervals as short as one month between infections (prior tweets)
9/9
This early study from South Africa showed the stealth nature of Omicron, many people were carrying it in their noses, a phenomenon not observed with pre Omicron variants.
Note this study was done at a blood bank, among donors.
Ignore the politics, but this news article from 10 months ago is a record of the *shortest interval I am aware of* in between two bouts of Omicron. See thread above for context.
In this landmark study, which is difficult to achieve, authors measured antibodies in samples drawn just before delta infection, and compared to those vaccinated people who did not get infected.
Those with higher neutralising antibody levels did not get infected.
2/
Note this was neutralising antibody level, which is difficult to measure and requires sophisticated equipment & facility.
Routine assays that look at Anti Spike protein antibody level will not predict this.
The value of this study is finding a correlate of protection, COP.
Although there is a lot of discussion about “keeping antibodies high” by vaccination, this study shows our immune response is multi-pronged and goes beyond just antibodies
T cells are key players who destroy virus-infected cells, thus preventing virus from spreading further
2/
Vaccination (and past infection) generates long lasting immune MEMORY that helps jump-start an immune response as soon as new infection occurs
The mutations in the new variant helps it escape the existing antibodies, BUT NOT the T CELLS
Tuesday COVID meeting updates 11 April, Cochin
(Meetings ongoing since onset of pandemic)
🔹Steep rise in COVID cases since April, see graphs
🔹More patients admitted to hospitals now
🔹Severe cases remain rare
🔹TPR at hospital rises from 0 to 42% in under 3 weeks
Thread 1/11
Until mid March, ILI (influenza-like- illness) was a mixed bag, with COVID being an occasional finding
Now, almost all ILI cases are COVID
All doctors observed that ICU admissions remain rare, compared to Delta wave
COVID pneumonias are rare, and mild in most cases
2/
Most patients can be treated as outpatient
Symptoms include extreme tiredness, fever (low grade to 101 F), cough, sore throat, occasional loss of taste/smell (remark), headache, a few with runny nose
🔹Rapid rise in TPR in hospitals in Ernakulam, Kerala, some areas more than others
🔹Healthcare workers testing positive
🔹COVID pneumonia observed in unvaccinated patients (yet again, see prior tweets)
🔹Most cases not severe
1/9
🔹 “Double Trouble” concern re. concurrent influenza (not seen in previous COVID waves)
🔹Many asymptomatic
🔹In one series of 8 hospitalised COVID patients, 6 had received booster dose. They improved.
❗️Shows that anyone can get infected - and take ill if risk factors.
2/
🔹Manpower shortage could occur in healthcare & other settings
🔹Younger (more mobile) people mainly involved now
🔹Three major festivals coming up in the next 3 weeks: Easter, Vishu, Eid al Fitr in that order. With all the mingling, it will reach more vulnerable people.
3/